Search clinical trials for: NPC-01

Total 19762 results

National Cancer Institute (NCI)

Terminated

Defining the Clinical Utility of EBV Antibody Screening to Identify Individuals Susceptible to Nasopharyngeal Carcinoma (NPC) Within High-Risk, Multiplex NPC Families

Nasopharyngeal Neoplasms

China
Inha University Hospital

Completed

Bright Light Therapy on Post-stroke Insomniawith Post-stroke Insomnia

Stroke Sequelae

Korea, Republic of
Aptissen SA
Donawa Lifescience

Completed

EVI-01-IT Safety Study

Knee Osteoarthritis

Italy
Federico II University

Unknown

Evaluation of the Efficacy of a New Infant Formula in Subjects With Cow's Milk Allergy

Cow's Milk Allergy

Italy
Galderma R&D

Not yet recruiting

Comparing Pain, Safety and Effectiveness of Restylane Skinboosters Vital Lido and Vital Without Lido in Dorsal Hand

Skin Aging of Dorsal Hands

China
University of Central Lancashire

Recruiting

Impact of 'SESL01' Lens on Computer Vision Syndrome

Computer Vision Syndrome

United Kingdom
Institut d'Anesthesiologie des Alpes Maritimes

Completed

N-acetyl-cysteine (NAC) and Kidney Graft Function

Brain Death | Chronic Renal Insufficiency

France
Vascular Solutions LLC

Completed

Safety and Efficacy of Endovenous Laser Ablation for the Resolution of Incompetent Perforator Veins (RELIEVE)

Venous Insufficiency

United States
The Aurum Institute NPC
Johns Hopkins University

Recruiting

Comparing Treatment Completion Of Daily Rifapentine & Isoniazid For One Month (1HP) To Weekly High Dose Rifapentine & Isoniazid For 3 Months (3HP) In Persons Living With HIV and in Household Contacts of Recently Diagnosed Tuberculosis Patients (1 to 3)

Tuberculosis | HIV Seropositivity | Household Contact

South Africa, India, Indonesia, Mozambique
Gaia AG
University of Giessen; Universitätsklinikum Hamburg-Eppendorf

Recruiting

Effectiveness of a Digital Health Application for Psoriasis

Psoriasis

Germany
Cliniques universitaires Saint-Luc- Université...

Terminated

Peptide Vaccinations Plus GM-CT-01 in Melanoma

Metastatic Melanoma

Belgium
Air Force Military Medical University, China

Recruiting

GNT Induction Treatment in Locally Advanced NPC

Nasopharyngeal Carcinoma

China
Dren Bio
Novotech

Recruiting

A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas

Aggressive NK Cell Leukemia | Hepatosplenic T-cell Lymphoma | Enteropathy-Associated T-Cell Lymphoma | Subcutaneous Panniculitis-Like T-Cell Lymphoma | Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma | LGLL - Large Granular Lymphocytic Leukemia | Primary Cutaneous T-Cell Lymphoma - Category and other conditions

United States, Australia, France, Spain
Kuros Biosurgery AG

Completed

Performance and Safety of I-020805 in Prevention of Cerebrospinal Fluid (CSF) Leakage Following Elective Craniotomy

Cerebrospinal Fluid Leakage

Germany, Hungary
First Affiliated Hospital Bengbu Medical College

Not yet recruiting

Intravenous Injection of Oncolytic Virus Injection (RT-01) in Patients With Relapsed or Refractory T-cell Lymphoma

T-cell Lymphoma | Virus | Intravenous Injection
Zhejiang Cancer Hospital

Recruiting

Radiotherapy Combined With Endostatin and Capecitabine for NPC

Nasopharyngeal Carcinoma

China
Pamela Youde Nethersole Eastern Hospital

Completed

NBI to Detect Post-RT Mucosal Residual NPC

Nasopharyngeal Carcinoma

Hong Kong
National Taiwan University Hospital

Completed

Functional Electrical Stimulation in Irradiated Nasopharyngeal Carcinoma (NPC)

Dysphagia
Medinol Ltd.

Completed

MedJ-01 Ridaforolimus Eluting Coronary Stent System Trial (JNIR) (JNIR)

de Novo or Restenosis Lesions

Japan
Yale University

Completed

CYstic Fibrosis bacterioPHage Study at Yale (CYPHY)

Cystic Fibrosis

United States
Intrepid Therapeutics, Inc.

Completed

An Evaluation of the Adrenal Suppression Potential and Pharmacokinetic Properties of CB-03-01 Cream in Subjects With Acne Vulgaris

Acne Vulgaris

United States
Pulmongene Ltd.

Recruiting

A Multiple Ascending Doses (MAD) Study of PMG1015 in Idiopathic Pulmonary Fibrosis Subjects

IPF

China
University of Vermont
Naval Medical Research Center; TD Vaccines A/S

Unknown

Campylobacter Jejuni Challenge Model Development: Dose Ranging Study

Campylobacter Infections

United States
Memorial Sloan Kettering Cancer Center
Johns Hopkins University; M.D. Anderson Cancer Center

Completed

A Multicenter Trial On The Utility and Impact Of Computed Tomography and Serum CA-125 In the Management of Newly Diagnosed Ovarian Cancer

Ovarian Cancer

United States
Ractigen Therapeutics.

Recruiting

A Study of RAG-01 in Patients With Non-muscle-invasive Bladder Cancer (NMIBC) Who Have Failed Bacillus Calmette Guérin (BCG) Therapy

Non-Muscle-Invasive Bladder Cancer (NMIBC)

Australia
Centre Oscar Lambret
University Hospital, Lille; Centre de Biologie Pathologie : Plateforme de Biologie...

Unknown

Cohort of Non-small Cell Lung Cancer With Mutation of the Nord Pas de Calais (CB(NPC)²) (CB(NPC)²)

Non-Small Cell Lung Cancer

France
National Institutes of Health Clinical Center (CC)

Completed

Peptide Vaccine to Prevent Recurrence of Nasopharyngeal Cancer

Nasopharyngeal Neoplasms

United States
Central South University

Unknown

Effect of Remote Ischemic Perconditioning on Acute Kidney Injury in Adult Valve Replace

Ischemic Reperfusion Injury | Rheumatic Disease of Heart Valve

China
Medtecx Co Ltd.

Completed

Evaluation of the The Neuromodulation System for the Treatment of Overactive Bladder Symptoms

Overactive Bladder

China
Oncopeptides AB

Terminated

A Study of Melphalan Flufenamide (Melflufen)-Dex or Pomalidomide-dex for RRMM Patients Refractory to Lenalidomide (OCEAN)

Multiple Myeloma

United States, Austria, Belgium, Czechia, Denmark, Estonia, France, Greece, Hungary, Israel, Italy, Korea, Republic of, Lithuania, Netherlands, Norway, Poland, Romania, Russian Federation, Spain, Taiwan, United Kingdom
Cyclo Therapeutics, Inc.

Active, not recruiting

Phase 3 Study to Evaluate Intravenous Trappsol(R) Cyclo(TM) in Pediatric and Adult Patients With Niemann-Pick Disease Type C1 (TransportNPC)

Niemann-Pick Disease, Type C1

United States, Taiwan, United Kingdom, Israel, Spain, Brazil, Italy, Australia, Turkey, Saudi Arabia, Argentina, Poland, Germany
Universitätsklinikum Hamburg-Eppendorf

Completed

Study About Patient Comfort and Long-term Outcome After Stapled Hemorrhoidopexy

Internal Hemorrhoids
National Cheng-Kung University Hospital

Completed

Clinical Evaluation of a Custom-made and Disposable Endoscope System for Biliary Tract

Neoplasms | Stone - Biliary | Biliary Tract

Taiwan
Afexa Life Sciences Inc

Terminated

GLU-xx Formulations in Individuals With Impaired Glucose Tolerance

Impaired Glucose Tolerance

United States
The Aurum Institute NPC
Coalition for Epidemic Preparedness Innovations

Recruiting

Phase 2a Trial to Evaluate Safety and Immunogenicity of COVID-19 Vaccine Strategies in HIV-infected/Uninfected Adults. (AUR1-8-341)

COVID-19

South Africa
Jiangxi Provincial Cancer Hospital
Sixth Affiliated Hospital, Sun Yat-sen University

Not yet recruiting

Dose Constraints for the Temporal Lobes of Intensity-modulated Radiotherapy Treatment Plans for Nasopharyngeal Carcinoma

Injury; Temporal Region
Trevi Therapeutics
Parexel

Completed

A Study of Nalbuphine (Extended Release) ER in Idiopathic Pulmonary Fibrosis (IPF) for Treatment of Cough (CANAL)

Cough | Idiopathic Pulmonary Fibrosis | Nalbuphine

United Kingdom
Sun Pharma Advanced Research Company Limited

Completed

Safety and Tolerability Study of K0706 in Subjects With Parkinson's Disease

Parkinson Disease

United States
CASI Pharmaceuticals, Inc.

Completed

A Multi-center, Open-label Study of Oral ENMD-2076 for the Treatment of Patients With Advanced Fibrolamellar Carcinoma

Advanced Adult Hepatocellular Carcinoma | Advanced Fibrolamellar Carcinoma

United States
Vedic Lifesciences Pvt. Ltd.

Completed

A Study to Evaluate Efficacy of Different Natural Ingredients in Improving Gut Health in Adults With Leaky Gut.

Gut Health

India
Guy's and St Thomas' NHS Foundation Trust
NanoMab Technology (UK) Limited

Recruiting

PD-L1 Expression in Cancer (PECan Study). (PECan)

Melanoma | Non-small Cell Lung Cancer

United Kingdom
University College, London

Completed

Investigating the Role of Ghrelin in Regulating Appetite and Energy Intake in Patients Following Bariatric Surgery (BARI-INSIGHT) (BARI-INSIGHT)

Obesity | Bariatric Surgery Candidate | Appetitive Behavior

United Kingdom
William Black
Immunotec Inc.

Completed

DGB-01 Effects on Endurance Exercise

Fatigue

United States
Nihon Pharmaceutical Co., Ltd

Completed

Clinical Trial of NPB-01 in Patients With Bullous Pemphigoid Unresponsive to Corticosteroids. (NPB-01)

Bullous Pemphigoid

Japan
Nasser Hanna, M.D.
Bristol-Myers Squibb; Hoosier Cancer Research Network

Terminated

Single Agent Chemotherapy +/- Nivolumab in Patients With Advanced Squamous or Non-squamous NSCLC With Primary Resistance to Prior PD-1 or PDL-1 Inhibitor

Lung Cancer | Squamous Cell Lung Cancer | Adenocarcinoma of the Lung | Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

United States
LG Chem

Completed

Clinical Study to Evaluate the Effectiveness and Safety of YVOIRE Y-Solution 720 Injected for Jawline Contouring

Jaw Volume Deficit

Austria, Poland
Sixth Affiliated Hospital, Sun Yat-sen University

Unknown

The Role of MSC in the Treatment of Fistulas in Patients With Perianal Crohn's Disease

Fistula | Crohn's Disease
Nihon Pharmaceutical Co., Ltd

Completed

Phase III Clinical Trial of NPB-01 in Patients With Bullous Pemphigoid Unresponsive to Corticosteroids

Bullous Pemphigoid

Japan
Zhongshan People's Hospital, Guangdong, China

Recruiting

Xerostomia-optimised IMRT Versus Standard IMRT in NPC

Nasopharyngeal Carcinoma ,Xerostomia,Radiotherapy

China
Eye & ENT Hospital of Fudan University
Changhai Hospital; Shanghai Zhongshan Hospital; Fujian Medical University Union... and other collaborators

Recruiting

Neoadjuvant vs Adjuvant in Locally Advanced Recurrent NPC

Recurrent Nasopharyngeal Carcinoma

China

Search clinical trials for: NPC-01

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Japan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations